Question 1

Does Mirae Asset Global Investments own ARWR stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Mirae Asset Global Investments holds 7,218 shares of ARWR (Arrowhead Pharmaceuticals), worth $472,418.

Question 2

How many shares of ARWR does Mirae Asset Global Investments own?

Accepted Answer

As of its Q3 2026 13F, Mirae Asset Global Investments holds 7,218 shares of ARWR (Arrowhead Pharmaceuticals).

Question 3

What is Mirae Asset Global Investments' ARWR position worth?

Accepted Answer

As of its Q3 2026 13F, Mirae Asset Global Investments' ARWR position is worth $472,418.

Question 4

Is Mirae Asset Global Investments buying or selling ARWR?

Accepted Answer

In Q3 2026, Mirae Asset Global Investments increased its ARWR position by 918 shares (+14.6%).

Question 5

When did Mirae Asset Global Investments first buy ARWR?

Accepted Answer

Mirae Asset Global Investments first reported ARWR in its Q2 2019 13F and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	7,218	+14.6%	$472,418	0.0%	$65.45	27
2026-Q2	Decreased	6,300	-13.8%	$513,513	0.0%	$81.51	0
2026-Q1	Increased	7,304	+10.7%	$457,961	0.0%	$62.70	27
2025-Q4	Increased	6,599	+23.5%	$438,108	0.0%	$66.39	29
2025-Q3	Increased	5,345	+0.2%	$184,349	0.0%	$34.49	23
2025-Q2	Increased	5,335	+29.5%	$84,293	0.0%	$15.80	27
2025-Q1	Decreased	4,121	-0.6%	$56,952	0.0%	$12.74	0
2024-Q4	Decreased	4,147	-7.8%	$78,627	0.0%	$18.80	0
2024-Q3	Increased	4,496	+21.3%	$88,436	0.0%	$19.37	26
2024-Q2	Decreased	3,708	-98.9%	$95,259	0.0%	$25.99	0
2024-Q1	Increased	327,782	+67.3%	$8M	0.0%	$28.60	40
2023-Q4	Decreased	195,985	-34.3%	$6M	0.0%	$30.60	0
2023-Q3	Increased	298,370	+8.6%	$8M	0.0%	$26.87	30
2023-Q2	Decreased	274,696	-16.9%	$9.8M	0.0%	$35.66	0
2023-Q1	Increased	330,658	+4.3%	$8.4M	0.0%	$25.40	29
2022-Q4	Increased	317,131	+25.3%	$12.9M	0.0%	$40.56	34
2022-Q3	Increased	253,126	+17.1%	$8.4M	0.0%	$33.05	32
2022-Q2	Increased	216,205	+44.4%	$7.6M	0.0%	$35.21	37
2022-Q1	Decreased	149,690	-15.4%	$6.9M	0.0%	$45.99	0
2021-Q4	Increased	176,925	+13.7%	$11.7M	0.0%	$66.30	32
2021-Q3	Increased	155,589	+24.6%	$9.7M	0.0%	$62.43	34
2021-Q2	Increased	124,836	+9.8%	$10.3M	0.0%	$82.82	30
2021-Q1	Increased	113,659	+81.0%	$7.5M	0.0%	$66.31	42
2020-Q4	Increased	62,794	+13.6%	$4.8M	0.0%	$76.73	31
2020-Q3	Increased	55,269	+38.3%	$2.4M	0.0%	$43.06	34
2020-Q2	Increased	39,974	+44.7%	$1.7M	0.0%	$43.19	35
2020-Q1	Increased	27,633	+24.5%	$795,000	0.0%	$28.77	30
2019-Q4	Decreased	22,190	-16.3%	$1.4M	0.0%	$63.43	0
2019-Q3	Increased	26,494	+241.4%	$747,000	0.0%	$28.18	40
2019-Q2	New	7,761	-	$206,000	0.0%	$26.50	32